LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report)’s stock price shot up 4.1% during trading on Friday . The stock traded as high as $9.30 and last traded at $9.14. 379,510 shares traded hands during mid-day trading, a decline of 43% from the average session volume of 667,603 shares. The stock previously closed at $8.78.
Analysts Set New Price Targets
Separately, TD Cowen downgraded LifeStance Health Group from an “outperform” rating to a “market perform” rating and boosted their price target for the company from $8.00 to $9.00 in a report on Monday, May 15th. Two equity research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $8.04.
LifeStance Health Group Stock Up 6.3 %
The company has a debt-to-equity ratio of 0.15, a current ratio of 1.17 and a quick ratio of 1.17. The business’s fifty day simple moving average is $8.64 and its two-hundred day simple moving average is $7.01. The company has a market cap of $3.52 billion, a PE ratio of -17.94 and a beta of 0.96.
LifeStance Health Group (NASDAQ:LFST – Get Free Report) last issued its quarterly earnings data on Wednesday, May 10th. The company reported ($0.09) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.02. LifeStance Health Group had a negative return on equity of 12.32% and a negative net margin of 20.63%. The company had revenue of $252.59 million for the quarter, compared to analyst estimates of $246.04 million. On average, analysts predict that LifeStance Health Group, Inc. will post -0.29 earnings per share for the current year.
Insider Buying and Selling at LifeStance Health Group
In other LifeStance Health Group news, insider Danish J. Qureshi sold 72,398 shares of the stock in a transaction on Wednesday, June 21st. The shares were sold at an average price of $9.03, for a total transaction of $653,753.94. Following the transaction, the insider now directly owns 4,583,404 shares of the company’s stock, valued at $41,388,138.12. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other LifeStance Health Group news, insider Warren Gouk sold 45,984 shares of the stock in a transaction that occurred on Wednesday, June 14th. The stock was sold at an average price of $8.95, for a total transaction of $411,556.80. Following the completion of the transaction, the insider now owns 5,925,982 shares of the company’s stock, valued at $53,037,538.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Danish J. Qureshi sold 72,398 shares of the stock in a transaction that occurred on Wednesday, June 21st. The shares were sold at an average price of $9.03, for a total value of $653,753.94. Following the transaction, the insider now directly owns 4,583,404 shares of the company’s stock, valued at approximately $41,388,138.12. The disclosure for this sale can be found here. Insiders have sold a total of 444,410 shares of company stock valued at $3,953,591 over the last ninety days. Corporate insiders own 8.50% of the company’s stock.
Institutional Trading of LifeStance Health Group
Large investors have recently bought and sold shares of the business. OLD National Bancorp IN purchased a new stake in shares of LifeStance Health Group in the fourth quarter valued at approximately $49,000. Dynamic Advisor Solutions LLC purchased a new stake in LifeStance Health Group in the 4th quarter valued at $56,000. Ameritas Investment Partners Inc. increased its stake in shares of LifeStance Health Group by 56.6% in the 1st quarter. Ameritas Investment Partners Inc. now owns 5,575 shares of the company’s stock worth $56,000 after acquiring an additional 2,016 shares during the last quarter. Squarepoint Ops LLC purchased a new position in shares of LifeStance Health Group during the 4th quarter worth $62,000. Finally, Point72 Hong Kong Ltd acquired a new position in shares of LifeStance Health Group during the 2nd quarter valued at about $63,000. Hedge funds and other institutional investors own 76.32% of the company’s stock.
LifeStance Health Group Company Profile
(Get Free Report)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Featured Articles
Receive News & Ratings for LifeStance Health Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for LifeStance Health Group and related companies with MarketBeat.com’s FREE daily email newsletter.